CNS infections in patients with hematological or oncological diseases (including cellular therapies): 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Background - Infections of the central nervous system (CNS) occur in up to 15% of patients with hematological or oncological diseases (HOD), particularly in high-risk populations. The most common causative agents are viruses or fungi. Prompt initiation of adequate diagnostic procedures and anti-infe...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 2026
|
| In: |
European journal of cancer
Year: 2026, Jahrgang: 232, Pages: 1-20 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2025.116103 |
| Online-Zugang: | Resolving-System, kostenfrei, Volltext: https://dx.doi.org/10.1016/j.ejca.2025.116103 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S095980492500989X 
|
| Verfasserangaben: | Rehsan Akdas, Enrico Schalk, Jannik Stemler, Stefan Schwartz, Uta Meyding-Lamadé, Jens P. Panse, William Krüger, Holger Rohde, Markus Ruhnke, Maximilian Christopeit, Klemens Angstwurm, Claus P. Heußel, Oliver A. Cornely, Daniel Teschner, Martin Schmidt-Hieber |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1945974842 | ||
| 003 | DE-627 | ||
| 005 | 20260220084030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251212s2026 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2025.116103 |2 doi | |
| 035 | |a (DE-627)1945974842 | ||
| 035 | |a (DE-599)KXP1945974842 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Akdas, Rehsan |e VerfasserIn |0 (DE-588)1390810623 |0 (DE-627)1961849933 |4 aut | |
| 245 | 1 | 0 | |a CNS infections in patients with hematological or oncological diseases (including cellular therapies) |b 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) |c Rehsan Akdas, Enrico Schalk, Jannik Stemler, Stefan Schwartz, Uta Meyding-Lamadé, Jens P. Panse, William Krüger, Holger Rohde, Markus Ruhnke, Maximilian Christopeit, Klemens Angstwurm, Claus P. Heußel, Oliver A. Cornely, Daniel Teschner, Martin Schmidt-Hieber |
| 264 | 1 | |c January 2026 | |
| 300 | |b Illustrationen | ||
| 300 | |a 20 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background - Infections of the central nervous system (CNS) occur in up to 15% of patients with hematological or oncological diseases (HOD), particularly in high-risk populations. The most common causative agents are viruses or fungi. Prompt initiation of adequate diagnostic procedures and anti-infective treatment is crucial, as treatment delays increase mortality. - Methods - We present an update of our previous guideline published in 2016 on the management of CNS infections in patients with HOD. The grading of recommendation strength and level of evidence followed the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) standards, based on a systematic literature review and a stepwise consensus process involving experts in internal medicine, hematology, oncology, infectious diseases, neurology, microbiology, and radiology. This process included several web-based meetings by the guideline panel, whereas the final recommendations were approved by the assembly of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology in September 2024. - Findings and interpretation - Evidence-based recommendations on the diagnosis and treatment of CNS infections in adult patients with HOD are essential in daily clinical practice to improve outcomes for patients at high risk of morbidity and mortality. | ||
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a CNS infections | |
| 650 | 4 | |a Diagnostics | |
| 650 | 4 | |a Guideline | |
| 650 | 4 | |a Hematological diseases | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a Schalk, Enrico |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stemler, Jannik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schwartz, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Meyding-Lamadé, Uta |e VerfasserIn |4 aut | |
| 700 | 1 | |a Panse, Jens P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krüger, William |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rohde, Holger |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ruhnke, Markus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Christopeit, Maximilian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Angstwurm, Klemens |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heußel, Claus Peter |e VerfasserIn |0 (DE-588)1048631389 |0 (DE-627)780769422 |0 (DE-576)40288146X |4 aut | |
| 700 | 1 | |a Cornely, Oliver A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Teschner, Daniel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmidt-Hieber, Martin |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 232(2026) vom: Jan., Artikel-ID 116103, Seite 1-20 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a CNS infections in patients with hematological or oncological diseases (including cellular therapies) 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) |
| 773 | 1 | 8 | |g volume:232 |g year:2026 |g month:01 |g elocationid:116103 |g pages:1-20 |g extent:20 |a CNS infections in patients with hematological or oncological diseases (including cellular therapies) 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1016/j.ejca.2025.116103 |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S095980492500989X |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260220 | ||
| 993 | |a Article | ||
| 994 | |a 2026 | ||
| 998 | |g 1048631389 |a Heußel, Claus Peter |m 1048631389:Heußel, Claus Peter |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1048631389 |e 950000PH1048631389 |e 950900PH1048631389 |e 50000PH1048631389 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 12 | ||
| 999 | |a KXP-PPN1945974842 |e 4920462670 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1016/j.ejca.2025.116103"],"eki":["1945974842"]},"title":[{"subtitle":"2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","title_sort":"CNS infections in patients with hematological or oncological diseases (including cellular therapies)","title":"CNS infections in patients with hematological or oncological diseases (including cellular therapies)"}],"language":["eng"],"person":[{"display":"Akdas, Rehsan","role":"aut","given":"Rehsan","family":"Akdas"},{"given":"Enrico","family":"Schalk","display":"Schalk, Enrico","role":"aut"},{"display":"Stemler, Jannik","role":"aut","given":"Jannik","family":"Stemler"},{"role":"aut","display":"Schwartz, Stefan","family":"Schwartz","given":"Stefan"},{"display":"Meyding-Lamadé, Uta","role":"aut","family":"Meyding-Lamadé","given":"Uta"},{"given":"Jens P.","family":"Panse","role":"aut","display":"Panse, Jens P."},{"display":"Krüger, William","role":"aut","given":"William","family":"Krüger"},{"given":"Holger","family":"Rohde","display":"Rohde, Holger","role":"aut"},{"family":"Ruhnke","given":"Markus","role":"aut","display":"Ruhnke, Markus"},{"display":"Christopeit, Maximilian","role":"aut","given":"Maximilian","family":"Christopeit"},{"family":"Angstwurm","given":"Klemens","display":"Angstwurm, Klemens","role":"aut"},{"given":"Claus Peter","family":"Heußel","display":"Heußel, Claus Peter","role":"aut"},{"given":"Oliver A.","family":"Cornely","role":"aut","display":"Cornely, Oliver A."},{"role":"aut","display":"Teschner, Daniel","family":"Teschner","given":"Daniel"},{"family":"Schmidt-Hieber","given":"Martin","display":"Schmidt-Hieber, Martin","role":"aut"}],"physDesc":[{"noteIll":"Illustrationen","extent":"20 S."}],"recId":"1945974842","origin":[{"dateIssuedKey":"2026","dateIssuedDisp":"January 2026"}],"relHost":[{"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"role":"isb","display":"European Association for Cancer Research"},{"display":"European School of Oncology","role":"isb"}],"id":{"issn":["1879-0852"],"eki":["266883400"],"zdb":["1468190-0"]},"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"EJC online"}],"pubHistory":["28.1992 -"],"recId":"266883400","disp":"CNS infections in patients with hematological or oncological diseases (including cellular therapies) 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)European journal of cancer","note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"part":{"pages":"1-20","text":"232(2026) vom: Jan., Artikel-ID 116103, Seite 1-20","extent":"20","volume":"232","year":"2026"},"origin":[{"dateIssuedDisp":"1992-","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","publisher":"Elsevier ; Pergamon Press","dateIssuedKey":"1992"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Rehsan Akdas, Enrico Schalk, Jannik Stemler, Stefan Schwartz, Uta Meyding-Lamadé, Jens P. Panse, William Krüger, Holger Rohde, Markus Ruhnke, Maximilian Christopeit, Klemens Angstwurm, Claus P. Heußel, Oliver A. Cornely, Daniel Teschner, Martin Schmidt-Hieber"]}} | ||
| SRT | |a AKDASREHSACNSINFECTI2026 | ||